The Microfibril-associated Glycoproteins (MAGPs) and the Microfibrillar Niche
Overview
Molecular Biology
Authors
Affiliations
The microfibril-associated glycoproteins MAGP-1 and MAGP-2 are extracellular matrix proteins that interact with fibrillin to influence microfibril function. The two proteins are related through a 60 amino acid matrix-binding domain but their sequences differ outside of this region. A distinguishing feature of both proteins is their ability to interact with TGFβ family growth factors, Notch and Notch ligands, and multiple elastic fiber proteins. MAGP-2 can also interact with αvβ3 integrins via a RGD sequence that is not found in MAGP-1. Morpholino knockdown of MAGP-1 expression in zebrafish resulted in abnormal vessel wall architecture and altered vascular network formation. In the mouse, MAGP-1 deficiency had little effect on elastic fibers in blood vessels and lung but resulted in numerous unexpected phenotypes including bone abnormalities, hematopoietic changes, increased fat deposition, diabetes, impaired wound repair, and a bleeding diathesis. Inactivation of the gene for MAGP-2 in mice produced a neutropenia yet had minimal effects on bone or adipose homeostasis. Double knockouts had phenotypes characteristic of each individual knockout as well as several additional traits only seen when both genes are inactivated. A common mechanism underlying all of the traits associated with the knockout phenotypes is altered TGFβ signaling. This review summarizes our current understanding of the function of the MAGPs and discusses ideas related to their role in growth factor regulation.
The Biomechanics of Fibrillin Microfibrils: Lessons from the Ciliary Zonule.
Rathaur P, Rodriguez J, Kuchtey J, Insignares S, Jones W, Kuchtey R Cells. 2025; 13(24.
PMID: 39768188 PMC: 11674075. DOI: 10.3390/cells13242097.
External Scaffold for Strengthening the Pulmonary Autograft in the Ross Procedure.
Nappi F, Nassif A, Schoell T Biomimetics (Basel). 2024; 9(11).
PMID: 39590246 PMC: 11591583. DOI: 10.3390/biomimetics9110674.
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer.
Huang J, Xu Y, Qi S, Zheng Q, Cui C, Liu L Discov Oncol. 2024; 15(1):202.
PMID: 38822944 PMC: 11144179. DOI: 10.1007/s12672-024-01044-7.
Smetanina M, Korolenya V, Sipin F, Oscorbin I, Sevostyanova K, Gavrilov K Biosci Rep. 2024; 44(5).
PMID: 38743016 PMC: 11139664. DOI: 10.1042/BSR20231938.
Wu H, Krystofiak E, Kuchtey J, Kuchtey R Am J Pathol. 2024; 194(7):1317-1328.
PMID: 38548269 PMC: 11317902. DOI: 10.1016/j.ajpath.2024.03.002.